Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|February 14, 2009
The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulatorDominique Fontanilla, Molly Johannessen, Abdol R Hajipour, et al.
Nuclear Medicine and Biology|January 12, 2013
Radiotracers for cardiac sympathetic innervation: transport kinetics and binding affinities for the human norepinephrine transporterDavid M Raffel, Wei Chen, Yong-Woon Jung, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 6, 2022
Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorderDeepak Cyril D'Souza, Shariful A Syed, L Taylor Flynn, et al.
Acta Crystallographica. Section C, Structural Chemistry|January 4, 2022
Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesAlexander M Sherwood, Robert B Kargbo, Kristi W Kaylo, et al.
Frontiers in Bioscience : a Journal and Virtual Library|March 17, 2005
Culture conditions influence uptake and intracellular localization of the membrane permeable cGMP-dependent protein kinase inhibitor DT-2Kevin F Foley, Sergio De Frutos, Kristina E Laskovski, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 17, 2009
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporterNicholas V Cozzi, Anupama Gopalakrishnan, Lyndsey L Anderson, et al.
European Journal of Pharmacology|November 27, 2012
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogsNicholas V Cozzi, Simon D Brandt, Paul F Daley, et al.
Pageof 5